相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lipid-based nanocarriers for delivery of small interfering RNA for therapeutic use
Deepti Parashar et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Oligonucleotides to the (Gene) Rescue: FDA Approvals 2017-2019
Jacqueline Ruger et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2020)
A promising approach to develop nanostructured lipid carriers from solid lipid nanoparticles: preparation, characterization, cytotoxicity and nucleic acid binding ability
Ezgi Oner et al.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY (2020)
KDM5 demethylases and their role in cancer cell chemoresistance
Johana Plch et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Rapid quantification of cellular proliferation and migration using ImageJ
C. Venter et al.
BIOTECHNIQUES (2019)
A comprehensive study of epigenetic alterations in hepatocellular carcinoma identifies potential therapeutic targets
Juan Bayo et al.
JOURNAL OF HEPATOLOGY (2019)
The current state and future directions of RNAi-based therapeutics
Ryan L. Setten et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
ProNGF increases breast tumor aggressiveness through functional association of TrkA with EphA2
Romain Leveque et al.
CANCER LETTERS (2019)
Efficient nanocarriers of siRNA therapeutics for cancer treatment
Md Abdus Subhan et al.
TRANSLATIONAL RESEARCH (2019)
Targeting of Histone Demethylases KDM5A and KDM6B Inhibits the Proliferation of Temozolomide-Resistant Glioblastoma Cells
Massimo Romani et al.
CANCERS (2019)
Rekindling RNAi Therapy: Materials Design Requirements for In Vivo siRNA Delivery
Byungji Kim et al.
ADVANCED MATERIALS (2019)
Lipid-Based DNA Therapeutics: Hallmarks of Non-Viral Gene Delivery
Jonas Buck et al.
ACS NANO (2019)
Androgen receptor-independent prostate cancer: an emerging clinical entity
Ilyas Sahin et al.
CANCER BIOLOGY & THERAPY (2018)
KDM5B demethylates H3K4 to recruit XRCC1 and promote chemoresistance
Wenxia Xu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2018)
EphA2 receptor is a key player in the metastatic onset of Ewing sarcoma
Silvia Garcia-Monclus et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Amphiphilic nanocarrier-induced modulation of PLK1 and miR-34a leads to improved therapeutic response in pancreatic cancer
Hadas Gibori et al.
NATURE COMMUNICATIONS (2018)
JIB-04, A Small Molecule Histone Demethylase Inhibitor, Selectively Targets Colorectal Cancer Stem Cells by Inhibiting the Wnt/β-Catenin Signaling Pathway
Min Seong Kim et al.
SCIENTIFIC REPORTS (2018)
Recent Advances in the Application of Vitamin E TPGS for Drug Delivery
Conglian Yang et al.
THERANOSTICS (2018)
Editorial: Adverse Effects of Cancer Chemotherapy: Anything New to Improve Tolerance and Reduce Sequelae?
Kulmira Nurgali et al.
FRONTIERS IN PHARMACOLOGY (2018)
Three-Dimensional in Vitro Cell Culture Models in Drug Discovery and Drug Repositioning
Sigrid A. Langhans
FRONTIERS IN PHARMACOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth
Janet K. Parrish et al.
Oncotarget (2018)
Systematic Screening of Commonly Used Commercial Transfection Reagents towards Efficient Transfection of Single-Stranded Oligonucleotides
Tao Wang et al.
MOLECULES (2018)
Jumonji Inhibitors Overcome Radioresistance in Cancer through Changes in H3K4 Methylation at Double-Strand Breaks
Juan Bayo et al.
CELL REPORTS (2018)
RNA interference-based therapy and its delivery systems
Xiuhui Chen et al.
CANCER AND METASTASIS REVIEWS (2018)
Preclinical Mammalian Safety Studies of EPHARNA (DOPC Nanoliposomal EphA2-Targeted siRNA)
Michael J. Wagner et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Beyond liposomes: Recent advances on lipid based nanostructures for poorly soluble/poorly permeable drug delivery
M. C. Teixeira et al.
PROGRESS IN LIPID RESEARCH (2017)
Small molecules targeting histone demethylase genes (KDMs) inhibit growth of temozolomide-resistant glioblastoma cells
Barbara Banelli et al.
ONCOTARGET (2017)
Taxane-Platin-Resistant Lung Cancers Co-develop Hypersensitivity to JumonjiC Demethylase Inhibitors
Maithili P. Dalvi et al.
CELL REPORTS (2017)
SETD2 alterations impair DNA damage recognition and lead to resistance to chemotherapy in leukemia
Brenton G. Mar et al.
BLOOD (2017)
Histone demethylase JMJD2A drives prostate tumorigenesis through transcription factor ETV1
Tae-Dong Kim et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Recent Progress in Histone Demethylase Inhibitors
Tom E. McAllister et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
HEDD: the human epigenetic drug database
Yunfeng Qi et al.
DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION (2016)
Vasculogenic Mimicry in Prostate Cancer: The Roles of EphA2 and PI3K
Hua Wang et al.
JOURNAL OF CANCER (2016)
Nanoparticles as transfection agents: a comprehensive study with ten different cell lines
Bernhard Neuhaus et al.
RSC ADVANCES (2016)
Preclinical and clinical development of siRNA-based therapeutics
Gulnihal Ozcan et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
Harnessing the potential of epigenetic therapy to target solid tumors
Nita Ahuja et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
ColonyArea: An ImageJ Plugin to Automatically Quantify Colony Formation in Clonogenic Assays
Camilo Guzman et al.
PLOS ONE (2014)
EphA2 enhances the proliferation and invasion ability of LNCaP prostate cancer cells
Peijie Chen et al.
ONCOLOGY LETTERS (2014)
KDM4/JMJD2 Histone Demethylases: Epigenetic Regulators in Cancer Cells
William L. Berry et al.
CANCER RESEARCH (2013)
Delivery materials for siRNA therapeutics
Rosemary Kanasty et al.
NATURE MATERIALS (2013)
A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growth
Lei Wang et al.
NATURE COMMUNICATIONS (2013)
Silencing of EphA2 inhibits invasion of human gastric cancer SGC-7901 cells in vitro and in vivo
W. Yuan et al.
NEOPLASMA (2012)
Emerging strategies for EphA2 receptor targeting for cancer therapeutics
Manish Tandon et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2011)
EphA2 Induces Metastatic Growth Regulating Amoeboid Motility and Clonogenic Potential in Prostate Carcinoma Cells
Maria Letizia Taddei et al.
MOLECULAR CANCER RESEARCH (2011)
Epha2 is a critical oncogene in melanoma
D. Udayakumar et al.
ONCOGENE (2011)
Rapid Generation of In Vitro Multicellular Spheroids for the Study of Monoclonal Antibody Therapy
Yen T. Phung et al.
JOURNAL OF CANCER (2011)
Transfection Efficiency of Cationic Lipids with Different Hydrophobic Domains in Gene Delivery
DeFu Zhi et al.
BIOCONJUGATE CHEMISTRY (2010)
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sreenath V. Sharma et al.
CELL (2010)
Eph receptors and ephrins in cancer: bidirectional signalling and beyond
Elena B. Pasquale
NATURE REVIEWS CANCER (2010)
EphA2 Mediates Ligand-Dependent Inhibition and Ligand-Independent Promotion of Cell Migration and Invasion via a Reciprocal Regulatory Loop with Akt
Hui Miao et al.
CANCER CELL (2009)
Mechanistic investigation of poly(ethylene imine)-based siRNA delivery: Disulfide bonds boost intracellular release of the cargo
Miriam Breunig et al.
JOURNAL OF CONTROLLED RELEASE (2008)
Potential of solid lipid nanoparticles in brain targeting
Indu Pal Kaur et al.
JOURNAL OF CONTROLLED RELEASE (2008)
RNA interference targeting EphA2 inhibits proliferation, induces apoptosis, and cooperates with cytotoxic drugs in human glioma cells
Zhangming Zhou et al.
SURGICAL NEUROLOGY (2008)
Activation of androgen receptor by histone demethylases JMJD2A and JMJD2D
Sook Shin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Silencing the receptor EphA2 suppresses the growth and haptotaxis of malignant mesothelioma cells
Najmunnisa Nasreen et al.
CANCER (2006)
Disruption of EphA2 receptor tyrosine kinase leads to increased susceptibility to carcinogenesis in mouse skin
Hong Guo et al.
CANCER RESEARCH (2006)
In vitro and in vivo imaging of cell migration: Two interdepending methods to unravel metastasis formation
D Palm et al.
SEMINARS IN CANCER BIOLOGY (2005)
Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery
CN Landen et al.
CANCER RESEARCH (2005)
Effect of cationic lipid and matrix lipid composition on solid lipid nanoparticle-mediated gene transfer
K Tabatt et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2004)
被撤回的出版物: EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma (Retracted article. See FEB, 2023)
MS Duxbury et al.
ONCOGENE (2004)
Overexpression and functional alterations of the EphA2 tyrosine kinase in cancer
MS Kinch et al.
CLINICAL & EXPERIMENTAL METASTASIS (2003)
分享论文
